Zhang Financial LLC Acquires New Stake in Colgate-Palmolive (NYSE:CL)

Zhang Financial LLC acquired a new stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 10,035 shares of the company's stock, valued at approximately $912,000.

Other hedge funds also recently bought and sold shares of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the third quarter valued at $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $64,000. True Wealth Design LLC grew its holdings in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after purchasing an additional 672 shares during the period. Finally, Continuum Advisory LLC increased its position in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after purchasing an additional 368 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.37% of the company's stock.

Colgate-Palmolive Stock Up 0.3 %

CL traded up $0.23 on Monday, reaching $88.79. The company's stock had a trading volume of 5,149,874 shares, compared to its average volume of 3,679,883. The company has a market capitalization of $72.55 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a 50 day moving average of $92.20 and a two-hundred day moving average of $97.76.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Barclays lowered their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating on the stock in a research note on Friday. Finally, Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of "Hold" and a consensus price target of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.